Circulating IL-6 has been associated with cancer progression and poor prognosis in melanoma, BC, and gastrointestinal tumors, among others (Salgado et al., 2003; Hoejberg et al., 2012; Vainer et al., 2018), but only few studies have assessed IL-6 cellular origin. Here, IL6 is linked to melanoma.